Lee Financial CO Biomarin Pharmaceutical Inc Transaction History

Lee Financial CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	SELL	$82.16 - $96.94 $164 - $193	-2 Reduced 6.25%	30 $3,000
Q2 2022 Aug 10, 2022	BUY	$71.48 - $86.85 $142 - $173	2 Added 6.67%	32 $2,000
Q1 2022 May 11, 2022	BUY	$74.28 - $92.69 $2,228 - $2,780	30 New	30 $2,000
Q3 2018 Nov 07, 2018	SELL	$93.92 - $105.72 $3,568 - $4,017	-38 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$77.67 - $92.63 $2,951 - $3,519	38 New	38 $3,000

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

Stay updated on Lee Financial CO with notifications on news.